Pfizer Inc vs First Trust NASDAQ Clean Edge Green Energy Idx Fd — how do they compare? Pfizer Inc trades at $27.77 (market cap $158.34B), while First Trust NASDAQ Clean Edge Green Energy Idx Fd trades at $49.35. The key difference: Pfizer Inc pays a 6.19% dividend while First Trust NASDAQ Clean Edge Green Energy Idx Fd pays none, and Pfizer Inc is trading nearer its 52-week high, First Trust NASDAQ Clean Edge Green Energy Idx Fd nearer its low. Which is the better fit depends on your goals.
| PFE | QCLN | |
|---|---|---|
Market Cap | $158.34B | — |
Volume | 29,869,932 | — |
Sector | Health | Sector/Thematic |
52-Week High | $29.02 | $68.47 |
52-Week Low | $23.60 | $37.69 |
Enterprise Value | $209.83B | — |
Dividend Yield | 6.19% | — |
Signals from Pluang's Aura AI — not financial advice
Pfizer (PFE) trades at $27.78, down 2.36% today, with a consensus price target of $28.33 suggesting modest upside. The stock shows mixed technical signals with bullish moving averages but neutral oscillators. Recent earnings have consistently beaten expectations, though revenue declined from pandemic peaks. The company maintains strong cash flow generation and a solid dividend yield of approximately 3.1%.
Pfizer presents a value opportunity with reasonable valuation metrics and dividend stability, but faces headwinds from post-COVID revenue normalization and patent expirations. The company's pipeline progress in obesity and oncology could drive future growth, though execution risks remain. Analyst sentiment leans cautious with 59% hold ratings.
QCLN trades at $50.57, up 2.31% today, with a mixed technical outlook showing bullish overall signals but bearish moving averages. The clean energy ETF benefits from geopolitical tensions accelerating renewable energy adoption globally. Recent news highlights strong performance relative to broader markets, with the fund rebounding ahead of midterm elections as policy support remains crucial for continued growth.
The ETF's outlook remains policy-dependent with significant upside potential from global energy transition trends, though regulatory uncertainty and political outcomes pose near-term risks. Current technical positioning near pivot point resistance at $51 suggests potential consolidation before next directional move.
Trailing returns across standard periods
Latest headlines on both assets
Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →QCLN invests in U.S.-listed companies engaged in clean energy technologies. It focuses on solar power, wind, electric vehicles, and energy storage, with major holdings in firms like Tesla, ON Semiconductor, and Rivian.
Read more on QCLN →